...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals
【24h】

Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals

机译:微芯片流腔系统表征健康个体全血血栓形成的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction A whole blood flow-chamber system, the Total Thrombus-formation Analysis System (T-TAS), was developed for quantitative analysis of platelet thrombus formation (PTF) using microchips with thrombogenic surfaces (collagen, PL chip; collagen plus tissue thromboplastin, AR chip) under shear stress conditions. We evaluated the usefulness of the T-TAS for assessing individual thrombogenicity compared with other platelet function tests. Materials and Methods Blood samples from 31 healthy volunteers were applied to the T-TAS to measure PTF starting time (T10: time to reach 10 kPa), occlusion time (T60 for PL chip; T80 for AR chip), and area under the curve (AUC10, area under curve until10 min for PL chip; AUC30, 30 min for AR chip) under various shear rates (1000, 1500, 2000 s- 1 for PL chip; 300 s- 1 for AR chip). Platelet functions were also tested using platelet aggregometry, the PFA-100 (collagen and epinephrine [C/EPI], collagen and adenosine diphosphate [C/ADP]), and the VerifyNow P2Y12 assay. Results Individual pressure waveforms, including PTF starting and ending points, varied among healthy subjects. In the PL chip, T10 and AUC10 showed a shear-dependent correlation with C/EPI or C/ADP. VerifyNow P2Y12 values were not significantly associated with the parameters of the T-TAS. Platelet counts were correlated with all AR measurements, and mostly with PL measurements. Conclusion The results of the T-TAS were associated with those of the PFA-100 in many respects, indicating that its characteristics are related to shear-induced PTF. The T-TAS showed few correlations with platelet aggregometry and the VerifyNow P2Y12 assay. The T-TAS may allow for the measurement of comprehensive parameters of individual thrombogenicity under whole blood flow conditions.
机译:简介开发了一种全血流腔系统,即总血栓形成分析系统(T-TAS),用于使用具有血栓形成表面的微芯片(胶原蛋白,PL芯片,胶原蛋白和组织凝血活酶, AR芯片)在剪切应力条件下。与其他血小板功能测试相比,我们评估了T-TAS在评估个体血栓形成性方面的有用性。材料和方法将31位健康志愿者的血样应用于T-TAS,以测量PTF起始时间(T10:达到10 kPa的时间),闭塞时间(PL芯片为T60; AR芯片为T80)以及曲线下面积(AUC10,对于PL芯片,曲线下的面积直到10分钟;对于AUC30,对于AR芯片,直到30分钟)在各种剪切速率下(对于PL芯片为1000、1500、2000 s-1;对于AR芯片,为300 s-1)。还使用血小板凝集法,PFA-100(胶原蛋白和肾上腺素[C / EPI],胶原蛋白和二磷酸腺苷[C / ADP])以及VerifyNow P2Y12检测法测试了血小板功能。结果在健康受试者中,各个压力波形(包括PTF的起点和终点)有所不同。在PL芯片中,T10和AUC10与C / EPI或C / ADP表现出剪切相关性。 VerifyNow P2Y12值与T-TAS的参数没有显着关联。血小板计数与所有AR测量相关,且大多数与PL测量相关。结论T-TAS的结果在很多方面与PFA-100的结果相关,表明其特性与剪切诱导的PTF有关。 T-TAS与血小板凝集法和VerifyNow P2Y12测定法几乎没有相关性。 T-TAS可以在全血流条件下测量个体血栓形成的综合参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号